April 25, 2020 European Medicines Agency (EMA) has reminded again regarding serious side effects associated with the use of Chloroquine and Hydroxychloroquine in patients suffering from COVID-19. EMA in their bulletin has stated that “Chloroquine and hydroxychloroquine are known to…
Apr 2, 2020 EMA has recommended that fosfomycin medicines given by infusion (drip) into a vein should only be used to treat serious infections when other antibiotic treatments are not suitable. Fosfomycin medicines given by mouth can continue to…
March 31, 2020 EMA has published its Regulatory Science Strategy to 2025 today. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines. It comes in response to the dramatic…
Recent Post
- India Cracks Down on Chloramphenicol & Nitrofurans in Food Producing Animals
- CDSCO Directs All Drug Manufacturers to Establish Pharmacovigilance Systems Under Schedule M
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
